Tandem Diabetes Care (TNDM)
(Delayed Data from NSDQ)
$42.84 USD
+0.27 (0.63%)
Updated Jun 21, 2024 04:00 PM ET
After-Market: $42.85 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Brokerage Reports
Tandem Diabetes Care, Inc. [TNDM]
Reports for Purchase
Showing records 181 - 200 ( 240 total )
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Q4 ahead of estimates, pipeline updates, reiterate STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
1Q15 Preview: Trends Look Better Than Initially Expected
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Proprietary Survey of Diabetes Educators Positive for Insulet and Tandem; Raising PT of PODD to $38
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Takeaways from DXCM and TNDM Management Meetings
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Takeaways from DXCM and TNDM Management Meetings
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Q4 ahead of estimates, pipeline updates, reiterate STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Insulin Pump Project: Historical survey of ~5,100 pump users (2007 - present)
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Solid 4Q Marks Turning Point; Expecting Positive Trends to Continue in 2015; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
MedTech Stocks To Watch This Week
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
MedTech Stocks To Watch This Week
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Q3 roughly inline, top-end of guidance reduced, reiterate STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Tempered Guidance Reflects Growing Pains; Long-term Thesis Intact; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Initiating Coverage on Insulin Pump Companies
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Company: Tandem Diabetes Care, Inc.
Industry: Wireline - National
Dropping Coverage Due to Realignment of Research Coverage
Provider: WEDBUSH SECURITIES INC.
Analyst: SUTHERLAND S
Company: Tandem Diabetes Care, Inc.
Industry: Wireline - National
Company: Tandem Diabetes Care, Inc.
Industry: Wireline - National
Company: Tandem Diabetes Care, Inc.
Industry: Wireline - National
Inline Revenue but Weak Adjusted EBITDA and EPS; Maintain NEUTRAL Rating and Lowering PT to $11.50
Provider: WEDBUSH SECURITIES INC.
Analyst: SUTHERLAND S